The University of Copenhagen (UCPH) is a research-led university with one of the largest institutions of research and education in the Nordic countries. UCPH is the highest ranked university in the Nordic region and number 20 in Europe. Copenhagen Centre for Regulatory Science (CORS) is based at the Department of Pharmacy, Faculty of Health and Medical Sciences at University of Copenhagen. CORS aims at being the international partner for academic leadership in regulatory science, research and education and to participate in building the regulatory framework that will make innovative medicinal products available to patients.
With its research, CORS aims to improve the drug regulatory system, by systematically studying its structure and behavior as well as designing new tools to facilitate regulatory decision-making.
Through improvement of the drug regulatory system CORS aims to enhance the drug regulatory system and contribute to an improvement of the health of the society. Furthermore, CORS carries out research that produces evidence to be used in drug regulatory decision-making.
Our contribution to the project
1Our experience of having worked with regulatory authorities, namely in pharmacovigilance.
2A wide network of regulatory experts, important for the project.
3Methodologies to support medical benefit-risk decision-making.
HTx: Next Generation HTA, a H2020 project, 2019-2023; IMI-PROTECT: The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, 2009-2015.